Leying Xi, Xixi Ji, Wenxiu Ji, Yue'e Yang, Yajie Zhang, & Hongyan Long. (2022). Jing-an oral liquid alleviates Tourette syndrome via the NMDAR/MAPK/CREB pathway in vivo and in vitro. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLeying Xi, Xixi Ji, Wenxiu Ji, Yue'e Yang, Yajie Zhang, and Hongyan Long. Jing-an Oral Liquid Alleviates Tourette Syndrome via the NMDAR/MAPK/CREB Pathway In vivo and In vitro. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationLeying Xi, et al. Jing-an Oral Liquid Alleviates Tourette Syndrome via the NMDAR/MAPK/CREB Pathway In vivo and In vitro. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.